ArticlePloS one2016

Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy.

Valeria Ricotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.